Publication date: Aug 09, 2019
Although stress has long been linked to substance use, craving and relapse, there are no available medications that target stress-induced substance use disorder (SUD). In particular, with the rise in opioid use, there is still a crucial need for developing effective pharmacological treatments that target and integrate the complexity of this disease. The long term goal of this project is to identify the key neuroendocrine pathways that are responsible for stress-induced craving in individuals with opioid use disorder (OUD) in order to better understand how they can be effectively treated.
|disease||MESH||substance use disorder|
- A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health.
- Effects of Dronabinol in Opioid Maintained Patients
- Medications for management of opioid use disorder.
- To fight the opioid epidemic, we must first confront the nature of addiction